Risk factors for treatment failure in scabies: a cohort study

被引:32
|
作者
Aussy, A. [1 ,2 ]
Houivet, E. [3 ,4 ]
Hebert, V. [1 ,2 ]
Colas-Cailleux, H. [1 ,2 ]
Laaengh, N. [1 ,2 ]
Richard, C. [1 ,2 ]
Ouvry, M. [1 ,2 ]
Boulard, C. [1 ,2 ]
Leger, S. [1 ,2 ]
Litrowski, N. [1 ,2 ]
Benichou, J. [3 ,4 ]
Joly, P. [1 ,2 ]
Bechu, S.
Mion-Mouton, N.
Lafaurie, O.
Barrel, A.
Pulluard, M.
Hamel, V.
Dore, M. X.
Duflo, E.
Lardans-Cassius, S.
Rzeznik, J. C.
Baricault, S.
机构
[1] Rouen Univ Hosp, Dept Dermatol, Rouen, France
[2] Univ Rouen Normandie, INSERM, U1234, Rouen, France
[3] Rouen Univ Hosp, Dept Biostat, Rouen, France
[4] Univ Rouen Normandie, INSERM, U1219, Rouen, France
关键词
ORAL IVERMECTIN; PREVALENCE; EPIDEMIOLOGY; CREAM;
D O I
10.1111/bjd.17348
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Treatment failure, which occurs in about one-third of cases, is considered as a major factor in the increasing incidence of scabies in developed countries. Objectives To identify predictors of treatment failure of scabies in ambulatory populations. Methods This multicentre study compared the clinical characteristics and treatment modalities between a group of patients with scabies treated successfully and another group who were not cured 3 months after antiscabies treatment. Results In total 210 patients with a diagnosis of scabies were included, comprising 98 patients in the treatment success group and 112 in the treatment failure group. The main risk factors for treatment failure were (i) the use of only one type of treatment, topical benzyl benzoate (BB) or oral ivermectin, vs. the combination of both treatments [odds ratio (OR) 2 center dot 15, 95% confidence interval (CI) 1 center dot 22-3 center dot 77]; (ii) the use of a single intake (vs. two) of oral ivermectin (OR 10 center dot 2. 95% CI 4 center dot 49-23 center dot 2); (iii) intake of ivermectin during a meal vs. on an empty stomach (OR 4 center dot 31, 95% CI 1 center dot 89-9 center dot 84); (iv) absence of decontamination of furnishings (OR 8 center dot 72, 95% CI 3 center dot 50-21 center dot 8), in particular sofa and cushions (OR 5 center dot 90, 95% CI 2 center dot 34-14 center dot 9), mattresses (OR 4 center dot 16, 95% CI 1 center dot 35-12 center dot 8) or car seats (OR 6 center dot 57, 95% CI 3 center dot 27-13 center dot 2) and (v) absence of written documents explaining treatment modalities (OR 5 center dot 18, 95% CI 2 center dot 57-10 center dot 4). In multivariate analysis, treatment failure was mainly associated with (i) use of a single intake (vs. two) of ivermectin (OR 6 center dot 62, 95% CI 2 center dot 71-16 center dot 2); (ii) use of BB alone vs. two intakes of ivermectin (OR 3 center dot 51, 95% CI 1 center dot 55-7 center dot 95) and (iii) absence of decontamination of furniture with acaricides (OR 5 center dot 81, 95% CI 1 center dot 96-16 center dot 7). Conclusions Use of topical BB alone and a single intake (vs. two) of ivermectin are predictors of treatment failure.
引用
收藏
页码:888 / 893
页数:6
相关论文
共 50 条
  • [21] Risk factors associated with failure of total ankle arthroplasty: a nationwide cohort study
    Suh, Dong Hun
    Han, Kyungdo
    Lee, Jin Woo
    Kim, Hak Jun
    Kim, Bongsung
    Koo, Bong Mo
    Kim, Hak Kyu
    Choi, Gi Won
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [22] Risk factors for recurrence of scabies: A retrospective study of scabies patients in a long-term care hospital
    Makigami, Kuniko
    Ohtaki, Noriko
    Ishii, Norihisa
    Tamashiro, Tetsuko
    Yoshida, Sadao
    Yasumura, Seiji
    JOURNAL OF DERMATOLOGY, 2011, 38 (09): : 874 - 879
  • [23] Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study
    Tuula Vasankari
    Pekka Holmström
    Jukka Ollgren
    Kari Liippo
    Maarit Kokki
    Petri Ruutu
    BMC Public Health, 7
  • [24] RISK FACTORS AND TREATMENT RESPONSE IN KAPOSIFORM HEMANGIOENDOTHELIOMA: A MULTICENTER COHORT STUDY
    Borst, Alexandra
    Eng, Whitney
    Griffin, Morgan
    Ricci, Kiersten
    Engel, Elissa
    Adams, Denise
    Dayneka, Jillian
    Cohen-Cutler, Sally
    Andreoli, Steven
    Wu, Melinda
    Wheeler, Alison
    Heym, Kenneth
    Crary, Shelley
    Nakano, Taizo
    Schulte, Rachael
    Setty, Bhuvana
    McLean, Thomas
    Pahl, Kristy
    Intzes, Stefanos
    Pateva, Irina
    Teitelbaum, Max
    Zong, Zili
    Li, Yimei
    Jeng, Michael
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S6 - S6
  • [25] The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors
    Marques, Juliana R.
    Guecheva, Temenouga N.
    Pfeifer, Paula M.
    Vieira, Daniela R.
    Pellanda, Lucia C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 277 : 247 - 247
  • [26] Risk factors for poor tuberculosis treatment outcome in Finland:: a cohort study
    Vasankari, Tuula
    Holmstrom, Pekka
    Ollgren, Jukka
    Liippo, Kari
    Kokki, Maarit
    Ruutu, Petri
    BMC PUBLIC HEALTH, 2007, 7 (1)
  • [27] The LifeLines Cohort Study: Prevalence and treatment of cardiovascular disease and risk factors
    van der Ende, M. Yldau
    Hartman, Minke H. T.
    Hagemeijer, Yanick
    Meems, Laura M. G.
    de Vries, Hendrik Sierd
    Stolk, Ronald P.
    de Boer, Rudolf A.
    Sijtsma, Anna
    van der Meer, Peter
    Rienstra, Michiel
    van der Harst, Pim
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 228 : 495 - 500
  • [28] Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study
    Gauthier, S. A.
    Glanz, B. I.
    Mandel, M.
    Tsagkaropoulos, Antonios
    Neema, Mohit
    Stankiewicz, James
    Arora, Ashish
    Duan, Yang
    Liptak, Zsuzsanna
    Egorova, Svetlana
    Buckle, Guy J.
    Bakshi, Rohit
    Guttmann, C. R. G.
    Khoury, S. J.
    Weiner, H. L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 284 (1-2) : 116 - 119
  • [29] Therapeutic failure in scabies : An observational study
    De Sainte Marie, B.
    Mallet, S.
    Gaudy-Marqueste, C.
    Baumstarck, K.
    Bentaleb, N.
    Loundou, A.
    Hesse, S.
    Monestier, S.
    Grob, J. -J.
    Richard, M. -A.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2016, 143 (01): : 9 - 15
  • [30] Are some children with empyema at risk for treatment failure with fibrinolytics? A multicenter cohort study
    Livingston, Michael H.
    Cohen, Eyal
    Giglia, Lucy
    Pirrello, David
    Mistry, Niraj
    Mahant, Sanjay
    Weinstein, Michael
    Connolly, Bairbre
    Himidan, Sharifa
    Butter, Andreana
    Walton, J. Mark
    JOURNAL OF PEDIATRIC SURGERY, 2016, 51 (05) : 832 - 837